Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07783542 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07783542 · ClinicalTrials.gov record · last posted 2026-08-24

ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

Name: ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa — clinical trial record (NCT07783542)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2

SponsorOruka Therapeutics, Inc.

Started2026-08-20

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This is a multicenter, randomized, double-blinded, placebo-controlled clinical study of ORKA-002 in adult participants with moderate-to-severe HS.

Trial Details

NCT Number	NCT07783542
Lead Sponsor	Oruka Therapeutics, Inc.
Conditions	Hidradenitis Suppurativa (HS)
Enrollment	200 participants
Start Date	2026-08-20
Primary Completion	2028-10 (estimated)
Study Completion	2029-09 (estimated)
Updated on ClinicalTrials.gov	2026-08-24